Tailoring In Vivo Delivery Strategies for Autoimmune Disease Immunobiology
3:45 pm - Tuesday 9th February 2027
- Evaluating how viral vectors, lipid nanoparticles and other delivery platforms interact with hyperactive innate and adaptive immune systems to minimise unwanted inflammatory responses
- Exploring how cytokine release, macrophage activation and dendritic cell responses differ across lupus, systemic sclerosis, myositis and other autoimmune indications to address disease-specific safety considerations
- Moving beyond a one-size-fits-all approach to develop indication-specific delivery and dosing strategies to improve therapeutic activity while reducing toxicity risks
